Bristol-Myers Squibb Canada
  • Home
  • |
  • Français
  • |
  • Contact Us
  • Company
    • Who We Are
    • Our Mission and Commitment
    • History
  • Products
    • Our Key Products
    • Product Information
    • Public Notices
  • Community
    • Events and Community News
    • Charitable Donations
    • Partnerships
  • News
    • News Releases
    • Media Room
    • RSS Feeds
  • Careers
    • Our Culture
    • What's in it for you
    • Join Us
  • Your Health
    • Health Information
    • Patient Stories
    • Patient Programs
    • Service and Reimbursement Programs
    • Product Information
  • Healthcare Professionals
    • Ask Our Experts
    • Service and Reimbursement Programs
    • Clinical Trials
    • Medical Grants & Sponsorships
    • Adverse Drug Events Reporting
    • Yervoy Tools for Healthcare Professionals and Patients
    • Yervoy Certification for Healthcare Professionals
Home » News » News Releases
  • facebookLinkedIn Share this site
  • Tell a friend
  • Print

News Releases

Subscribe to the RSS feed for this category

Viewing Category: Cardiovascular

  • LAVAL (QUEBEC), CANADA — June 5, 2007

    Health Canada's Approval of an Expanded Indication for Plavix® (Clopidogrel Bisulfate) Now Offers Protection from All Types of Heart Attacks

    Categories: Cardiovascular | Plavix

News
  • News Releases
  • Media Room
  • RSS Feeds

Latest News

Keep up-to-date with the Latest News from BMS Canada.

 
  • Your Health

    Support you can trust.

  • Healthcare Professionals

    Information & Resources.

  • Jobs @ BMS Canada

    Looking for a great career?

Sitemap

  • Company
  • Products
  • Community
  • News
  • Careers
  • Investors
  • Visit BMS.com
©2012 Bristol-Myers Squibb Canada
Your use of the information on this site is subject to the terms of our legal notice and privacy policy.

Disclaimer

You are now leaving Bristol-Myers Squibb Canada Web site.

Links to other sites are provided for your convenience. Bristol-Myers Squibb Canada accepts no responsibility for the content of linked sites.

or Cancel